Gland Pharma
BSE: 543245 | NSE: GLAND | ISIN: INE068V01023 | SECTOR: Biotechnology & DrugsRatios
- Management Effectiveness
- Margins
- Financial Strength
- Valuation
- Income Statement
- Growth
- Per Share Data
- Price and Volume
Return on average equity - 5 year average
17.03Net Income/employee - trailing 12 month
14,36,691.00Revenue/employee - most recent fiscal year
78,59,066.00Return on investment - most recent fiscal year
10.21Return on average assets - most recent fiscal year
9.40Receivables turnover - most recent fiscal year
3.18Return on investment - trailing 12 month
-Return on average assets - trailing 12 month
-Inventory turnover - most recent fiscal year
1.08Inventory turnover - trailing 12 month
-Revenue/employee - trailing 12 month
1,07,13,810.00Return on average assets - 5 year average
15.16Net Income/employee - most recent fiscal year
16,93,502.00Return on average equity - trailing 12 month
-Receivables turnover - trailing 12 month
-Asset turnover - most recent fiscal year
0.44Asset turnover - trailing 12 month
-Return on average equity - most recent fiscal year
10.33Return on investment - 5 year average
16.69